Marvel Custom Solutions has partnered with Seb Tucknott, the founder of the online platform IBDRelief and pharmaceutical company Takeda, to create a new ... Read more

August 14, 2017August 18, 2017

NIH Unit Awards Georgia Researchers $1.4 Million to Study Novel IBD Therapies

Crohn's Disease, News

Researchers at Georgia State University’s Institute for Biomedical Sciences won a $1.4 million federal grant to study novel therapeutic approaches to treat inflammatory bowel ... Read more

August 11, 2017August 21, 2017

Drop in Levels of Specific Enzyme Seen to Favor Development of Pro-Inflammatory T-Cells

Crohn's Disease, News

Low levels of the enzyme PTPN2 promote the development a group of T-cells with pro-inflammatory properties, contributing to syndromes such as Crohn’s disease, scientists ... Read more

August 11, 2017August 18, 2017

Crohn’s Disease Questions: Words that Hurt

Columns, Crohn's Disease, It Could Be Worse - a column by Mary Horsley

Editor’s note: In the second part of the series “Crohn’s Disease Questions,” Mary Horsley discusses comments about IBD that can hurt. Read ... Read more

August 10, 2017October 9, 2017

Market Survey Shows Potential of JAK Inhibitors to Treat IBD

Crohn's Disease, News

Directors from pharmaceutical and health insurance companies and gastroenterologists in the United States have expressed a positive opinion overall about the use ... Read more

August 10, 2017August 18, 2017

Psoriasis Patients in Phase 1 Trial Receiving KY1005-CT01, a Potential Bowel Disease Therapy

Crohn's Disease, News

A 24th psoriasis patient has received KY1005-CT01 in a Phase 1 clinical trial of the treatment designed to fight the autoimmune disorder ... Read more

August 9, 2017August 18, 2017

Letting Well-meaning Friends Off the Hook

Columns, Crohn's Corner - a column by Judy Walters, Crohn's Disease

So, of course my friends all know that I have Crohn’s. It’s not something I hide. But I’m not usually forthright ... Read more